Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Cited by (1,000)

Items 701–800 of 1,000

1. Differential Effects of LPS and 6-OHDA on Microglia’s Morphology in Rats: Implications for Inflammatory Model of Parkinson’s Disease
   Irving Parra, Isabel Martínez, Gabriel Ramirez‐Garcia, Yousef Tizabi, Liliana Mendieta · 2019 · Neurotoxicity Research
2. Intranigral Administration of β ‐Sitosterol‐ β ‐D‐Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
   Claudia Luna-Herrera, Irma Alicia Martínez-Dávila, Luis Oskar Soto-Rojas, Yazmin Montserrat Flores-Martinez, Manuel A. Fernandez-Parrilla, José Ayala-Dávila, Bertha Alicia León‐Chávez, Guadalupe Soto-Rodríguez, Víctor Manuel Blanco-Álvarez, Francisco E. López-Salas et al. · 2020 · Journal of Immunology Research
3. Targeting Progressive Neuroaxonal Injury
   Amit Bar‐Or, Peter Rieckmann, Anthony L. Traboulsee, Voon Wee Yong · 2011 · CNS Drugs
4. Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system
   H. C. Yu, Shengjie Feng, Pei‐Ling Chao, A. M. Y. Lin · 2010 · Neuropathology and Applied Neurobiology
5. Potential role of α‐synuclein in neurodegeneration: studies in a rat animal model
   George Stoica, Gina F. Lungu, Nicole L. Bjorklund, Giulio Taglialatela, Xing Zhang, Veronica M. Chiu, Herbert H. Hill, James O. Schenk, Ian V.J. Murray · 2012 · Journal of Neurochemistry
6. Nose-to-brain co-delivery of repurposed simvastatin and BDNF synergistically attenuates LPS-induced neuroinflammation
   Dharani Manickavasagam, Li Lin, Moses O. Oyewumi · 2019 · Nanomedicine Nanotechnology Biology and Medicine
7. Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies
   Hiroaki Sekiya, Tomoyasu Matsubara, Michael A. Deture, Dennis W. Dickson · 2025 · Molecular Neurodegeneration
8. Apocyanin, NADPH oxidase inhibitor prevents lipopolysaccharide induced α-synuclein aggregation and ameliorates motor function deficits in rats: Possible role of biochemical and inflammatory alterations
   Neha Sharma, Monika Kapoor, Bimla Nehru · 2015 · Behavioural Brain Research
9. From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
   Antonio Heras‐Garvin, Nadia Stefanova · 2020 · Frontiers in Synaptic Neuroscience
10. Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
    Alix Booms, Gerhard A. Coetzee · 2021 · Frontiers in Cellular Neuroscience
11. Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson’s Disease
    Matthew K. Boag, Angus Roberts, Vladimir Nikolaevich Uversky, Linlin Ma, Des Raymond Richardson, Dean L. Pountney · 2022 · International Journal of Molecular Sciences
12. Gut microbiota, pathogenic proteins and neurodegenerative diseases
    Wei Wei, Shixu Wang, Chongchong Xu, Xuemei Zhou, Xinqing Lian, Lin He, Kuan Li · 2022 · Frontiers in Microbiology
13. Mixed pathology as a rule, not exception: Time to reconsider disease nosology
    Yaping Chu, Warren D. Hirst, Jeffrey H. Kordower · 2023 · Handbook of clinical neurology
14. Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems
    Felitsiya Shakola, Parul Suri, Matteo Ruggiu · 2015 · Biomolecules
15. Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies
    Christelle En Lin Chua, Bor Luen Tang · 2011 · Brain Research Reviews
16. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons
    Shijun Wang, Chun‐Hsien Chu, Mingri Guo, Lulu Jiang, Hui Nie, Wei Zhang, Belinda C. Wilson, Yang Li, Tessandra Stewart, Jau‐Shyong Hong et al. · 2016 · Journal of Neuroinflammation
17. The Microglial Response to Neurodegenerative Disease
    Wilbur M. Song, Marco Colonna · 2018 · Advances in immunology
18. Recent advances of nanomaterials for intervention in Parkinson’s disease in the context of anti-inflammation
    Ruoyu Zhang, Xiaotong Chen, Yuanyuan Cheng, Zixuan Chen, Xiaoqiong Li, Yulin Deng · 2023 · Coordination Chemistry Reviews
19. The emerging role of disease-associated microglia in Parkinson’s disease
    Ritika R. Samant, David G. Standaert, Ashley S. Harms · 2024 · Frontiers in Cellular Neuroscience
20. Non-cell-autonomous actions of α-synuclein: Implications in glial synucleinopathies
    Somin Lim, Han‐Joon Kim, Dong‐Kyu Kim, Seung‐Jae Lee · 2018 · Progress in Neurobiology
21. CRISPR/Cas9 Editing for Gaucher Disease Modelling
    Eleonora Pavan, Maximiliano Ormazábal, Paolo Peruzzo, Emilio Vaena, Paula Adriana Rozenfeld, Andrea Dardis · 2020 · International Journal of Molecular Sciences
22. Neuroprotective effects of Pulicaria undulata essential oil in rotenone model of parkinson's disease in rats: Insights into its anti-inflammatory and anti-oxidant effects
    Marwa Yousry Issa, Marwa I. Ezzat, Rabab Hamed Sayed, Eman Maher Elbaz, Farghaly Abdelhamid Omar, Engy Mohsen · 2020 · South African Journal of Botany
23. T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
    Sonia George, Trevor Tyson, Nolwen L. Rey, Rachael T. C. Sheridan, Wouter Peelaerts, Katelyn Becker, Emily Schulz, Lindsay K. Meyerdirk, Amanda Rae Burmeister, Christian Ulrich von Linstow et al. · 2021 · Journal of Parkinson s Disease
24. Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs
    Elisa Medrano-Jiménez, Karla F. Meza‐Sosa, Jose A. Urban Aragon, Ismael Secundino, Gustavo Pedraza-Alva, Leonor Pérez-Martínez · 2022 · Journal of Leukocyte Biology
25. Pathways towards an effective immunotherapy for Parkinson’s disease
    Jessica A.L. Hutter-Saunders, Rodney Lee Mosley, Howard Eliot Gendelman · 2011 · Expert Review of Neurotherapeutics
26. Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.
    Edward C. Lauterbach · 2016 · Europe PMC (PubMed Central)
27. Neuroinflammation and Neurodegeneration
    Inelia Morales, Gonzalo A. Farias, Nicole Cortés, Ricardo Benjamin Maccioni · 2016 · InTech eBooks
28. Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity
    Neal K. Bennett, Rebecca Chmielowski, Dalia S. Abdelhamid, Jonathan J. Faig, Nicola Louise Francis, Jean Baum, Zhiping P. Pang, Kathryn E. Uhrich, Prabhas V. Moghe · 2016 · Biomaterials
29. Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
    Marianne von Euler Chelpin, Thomas Vorup‐Jensen · 2017 · Scandinavian Journal of Immunology
30. Ganglioside Metabolism and Parkinson's Disease
    John Forsayeth, Piotr Hadaczek · 2018 · Frontiers in Neuroscience
31. Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
    Helena Borland Madsen, Frederik Vilhardt · 2017 · International Journal of Molecular Sciences
32. Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
    Natalia Jiménez-Moreno, Jon D. Lane · 2020 · Oxidative Medicine and Cellular Longevity
33. Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases
    Mohammadmahdi Sabahi, Asef Joshaghanian, Mahsa Dolatshahi, Parnian Jabbari, Farzaneh Rahmani, Nima Rezaei · 2021 · Journal of Molecular Neuroscience
34. Effect of Subthalamic Stimulation and Electrode Implantation in the Striatal Microenvironment in a Parkinson’s Disease Rat Model
    Ana Carolina Pinheiro Campos, Raquel Chacon Ruiz Martinez, Aline Vivian Vatti Auada, Ivo Lebrun, Erich Talamoni Fonoff, Clement Hamani, Rosana L. Pagano · 2022 · International Journal of Molecular Sciences
35. Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors
    Staffan Holmqvist, Marinka Brouwer, Mehdi Djelloul, Alejandro Garcia Diaz, Michael J. Devine, Anna Hammarberg, Karina Fog, Tilo Kunath, Laurent Roybon · 2015 · Stem Cell Research
36. α-Synuclein is a pathological link and therapeutic target for Parkinson’s disease and traumatic brain injury
    Md Shahaduzzaman, Sandra Acosta, Paula C. Bickford, Cesar V. Borlongan · 2013 · Medical Hypotheses
37. Let’s make microglia great again in neurodegenerative disorders
    Marie‐Victoire Guillot‐Sestier, Terrence Town · 2017 · Journal of Neural Transmission
38. Advances in modelling alpha-synuclein-induced Parkinson’s diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species
    Anna Rosa Carta, Laura Boi, Augusta Pisanu, Maria Francesca Palmas, Ezio Carboni, Alfonso De Simone · 2020 · Journal of Neuroscience Methods
39. Macrophages are unsuccessful in clearing aggregated alpha‐synuclein from the gastrointestinal tract of healthy aged Fischer 344 rats
    Phillips, Robert J., Billingsley, Cherie N., Powley, Terry L. · 2013 · The Anatomical Record
40. iPLA2β Knockout Mouse, a Genetic Model for Progressive Human Motor Disorders, Develops Age-Related Neuropathology
    Helene C. Blanchard, Ameer Y. Taha, Yewon Cheon, Hyung‐Wook Kim, JOHN W. TURK, Stanley Isaac Rapoport · 2014 · Neurochemical Research
41. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson’s Disease Models
    Ji Ae Lee, Hyo Jin Son, Ki Duk Park, Se Hee Han, Nari Shin, Ji Hyun Kim, Hye Ri Kim, Dong Jin Kim, Onyou Hwang · 2015 · Neurotoxicity Research
42. Plasma cytokine profile in synucleinophaties with dementia
    Tatiana S. Usenko, Mikhail A. Nikolaev, Irina V. Miliukhina, Anastasia I. Bezrukova, Konstantin A. Senkevich, N. A. Gomzyakova, I. A. Beltceva, N. M. Zalutskaya, E. Gracheva, Alla Timofeeva et al. · 2020 · Journal of Clinical Neuroscience
43. The Chemically-Modified Tetracycline COL-3 and Its Parent Compound Doxycycline Prevent Microglial Inflammatory Responses by Reducing Glucose-Mediated Oxidative Stress
    Nilson Carlos Ferreira‐Junior, Maurício dos Santos Pereira, Nour Francis, Paola Ramírez, Paula Martorell, Florencia González‐Lizárraga, Bruno Figadère, Rosana Nieves Chehín, Elaine Aparecida Del Bel, Rita Raisman‐Vozari et al. · 2021 · Cells
44. Glia as antigen-presenting cells in the central nervous system
    Pearl A. Sutter, Stephen J. Crocker · 2022 · Current Opinion in Neurobiology
45. Hippocampal proliferation is increased in presymptomatic Parkinson’s disease and due to microglia
    Doorn, Karlijn J., Drukarch, Benjamin, van Dam, Anne-Marie, Lucassen, Paul J. · 2014 · Neural Plasticity
46. Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response
    Rami R. Ajjuri, Janis M. O’Donnell · 2013 · Journal of Visualized Experiments
47. Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations
    Lynnae M. Patrias, Andrea C. Klaver, Mary P. Coffey, David A. Loeffler · 2010 · Clinical & Experimental Immunology
48. Nanomedicine and its Application in Treatment of Microglia-mediated Neuroinflammation
    Nimmi Baby, Radhika Patnala, Eng‐Ang Ling, Shaikali Thameem Dheen · 2014 · Current Medicinal Chemistry
49. NADPH oxidase-derived production of reactive oxygen species is involved in learning and memory impairments in 16-month-old female rats
    Hongwei Kan, Wen Hu, Yuchan Wang, Wangyang Wu, Yanyan Yin, Yan Liang, Chunyan Wang, Dake Huang, Weizu Li · 2015 · Molecular Medicine Reports
50. Inflammasome and Cognitive Symptoms in Human Diseases: Biological Evidence from Experimental Research
    So Yeong Cheon, Jeongmin Kim, So Yeon Kim, Eun Jung Kim, Bon‐Nyeo Koo · 2020 · International Journal of Molecular Sciences
51. Raft aggregation with specific receptor recruitment is required for microglial phagocytosis of Aβ42
    Dixie‐Ann Persaud‐Sawin, Lynna Banach, Gaylia Jean Harry · 2008 · Glia
52. Ablation of polyamine catabolic enzymes provokes Purkinje cell damage, neuroinflammation, and severe ataxia
    Kamyar A. Zahedi, Marybeth Brooks, Sharon Barone, Negah Rahmati, Tracy Murray Stewart, Matthew Dunworth, Christina E. DeStefano Shields, Nupur Dasgupta, Steve Davidson, Diana M. Lindquist et al. · 2020 · Journal of Neuroinflammation
53. Mitigating neuroinflammation in Parkinson's disease: Exploring the role of proinflammatory cytokines and the potential of phytochemicals as natural therapeutics
    Prashant Kumar Sharma, Abhinoy Kishore, Indranil De, Swarnima Negi, Gulshan Kumar, Sahil Bhardwaj, Manish P. Singh · 2023 · Neurochemistry International
54. Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
    Alexander J. Hull, Magda Luciana Atilano, Laith Gergi, Kerri J. Kinghorn · 2024 · Philosophical Transactions of the Royal Society B Biological Sciences
55. Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease
    Sang Myun Park, Kwang Soo Kim · 2013 · Prion
56. Neuroprotective effect of oral S/B remedy (Scutellaria baicalensis Georgi and Bupleurum scorzonerifolfium Willd) on iron-induced neurodegeneration in the nigrostriatal dopaminergic system of rat brain
    Anya Maan‐Yuh Lin, Y.H. Ping, Guanyu Chang, Jia‐Yi Wang, Jen‐Hwey Chiu, C.D. Kuo, C.-W. Chi · 2011 · Journal of Ethnopharmacology
57. Excessive Iron and α-Synuclein Oligomer in Brain are Relevant to Pure Apathy in Parkinson Disease
    Fang Wang, Shuyang Yu, Li-Jun Zuo, Chen-Jie Cao, Yang Hu, Ze-Jie Chen, Ying‐shan Piao, Yajie Wang, Xiaomin Wang, Shengdi Chen et al. · 2016 · Journal of Geriatric Psychiatry and Neurology
58. Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor
    Kelsey E. Lesteberg, John David Beckham · 2018 · Viral Immunology
59. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion
    Yuyuan Gao, Hongmei Tang, Kun Nie, Ruiming Zhu, Liang Gao, Shujun Feng, Limin Wang, Jiehao Zhao, Zhiheng Huang, Yuhu Zhang et al. · 2019 · Behavioural Brain Research
60. Prospective longitudinal evaluation of cytokines in mild cognitive impairment due to AD and Lewy body disease
    Alan J. Thomas, Calum Alexander Hamilton, Paul C. Donaghy, Carmen M. Martin-Ruiz, Christopher M. Morris, Nicola Barnett, Kirsty Olsen, John‐Paul Taylor, John Tiernan O'Brien · 2020 · International Journal of Geriatric Psychiatry
61. TREM2 deficiency exacerbates cognitive impairment by aggravating α-Synuclein-induced lysosomal dysfunction in Parkinson’s disease
    Baoyu Zhu, Jiezhu Feng, Xiaomei Liang, Zhongling Fu, Mengshi Liao, Tongtong Deng, Kaicheng Wang, Jianwei Xie, Jieshan Chi, Lu Yang et al. · 2025 · Cell Death Discovery
62. N ‑Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge
    Shih‐Chang Hsueh, Weiming Luo, David Tweedie, Dong Seok Kim, Yu Kyung Kim, Inho Hwang, Jung-Eun Gil, Baek‐Soo Han, Yung Hsiao Chiang, Warren R. Selman et al. · 2021 · ACS Pharmacology & Translational Science
63. Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
    Karina Joppe, Lars Tatenhorst, Lucas Caldi Gomes, Shuyu Zhang, Mojan Parvaz, Eleonora Carboni, Anna‐Elisa Roser, Hazem Eldebakey, Mathias Bähr, Katarina Vogel‐Mikuš et al. · 2021 · Journal of Neurochemistry
64. Blood brain barrier-on-a-chip to model neurological diseases
    S.C. Reshma, Kizhakkepurakkal Balachandran Megha, S. Amir, S. Rukhiya, P.V. Mohanan · 2023 · Journal of Drug Delivery Science and Technology
65. MALAT1 Mediates α-Synuclein Expression through miR-23b-3p to Induce Autophagic Impairment and the Inflammatory Response in Microglia to Promote Apoptosis in Dopaminergic Neuronal Cells
    Xin Geng, Yanghong Zou, Shipeng Li, Renli Qi, Hualin Yu, Jinghui Li · 2023 · Mediators of Inflammation
66. Repurposing of pexidartinib for microglia depletion and renewal
    Marc-Philipp Weyer, Jenny Strehle, Michael K. E. Schäfer, Irmgard Tegeder · 2023 · Pharmacology & Therapeutics
67. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells
    Roger J. Bick, Brian J. Poindexter, Marylee M. Kott, Yang an Liang, Kha Dinh, Berneet Kaur, Diane L. M. Bick, Marie–Françoise Doursout, Mya Caryn Schiess · 2008 · Brain Research
68. Investigational α-synuclein aggregation inhibitors: hope for Parkinson’s disease
    Nóra Török, Zsófia Majláth, Levente Szalárdy, László Vécsei · 2016 · Expert Opinion on Investigational Drugs
69. Hirano body expression impairs spatial working memory in a novel mouse model
    Matthew Furgerson, Jason K Clark, Jonathon D. Crystal, John J. Wagner, Marcus Fechheimer, Ruth Furukawa · 2014 · Acta Neuropathologica Communications
70. Counteracting neuroinflammation in experimental Parkinson’s disease favors recovery of function: effects of Er-NPCs administration
    Stephana Carelli, Toniella Giallongo, Zuzana Tonelli Gombalová, Federica Rey, Maria Carlotta Gorio, Massimiliano Mazza, Anna Maria Di Giulio · 2018 · Journal of Neuroinflammation
71. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
    Deepanjali Tripathy, J. Chakraborty, Kochupurackal P. Mohanakumar · 2015 · Free Radical Research
72. Brain Damage - Bridging Between Basic Research and Clinics
    Alina González-Quevedo · 2012 · InTech eBooks
73. Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s Disease
    Bethany A. Grimmig, Josh M. Morganti, Kevin R. Nash, Paula C. Bickford · 2016 · Brain Sciences
74. SNARE Proteins Mediate α-Synuclein Secretion via Multiple Vesicular Pathways
    Xiaofang Zhao, Yuan Guan, Fengwei Liu, Shuxin Yan, Yalong Wang, Meiqin Hu, Yuhong Li, Rena Li, Claire Xi Zhang · 2021 · Molecular Neurobiology
75. Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
    Erika d. l. R. M. Cabrera Ranaldi, Karen Nuytemans, Anisley Martinez, Corneliu C. Luca, Robert W. Keane, Juan Pablo de Rivero Vaccari · 2023 · Pharmaceuticals
76. Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer’s disease diagnosis and differential diagnosis
    Zhen Guo, Chen Tian, Yang Shi, Xueru Song, Wei Yin, Qing‐Qing Tao, Jie Liu, Guo-Ping Peng, Zhi‐Ying Wu, Yan‐Jiang Wang et al. · 2024 · Acta Neuropathologica Communications
77. Proteomics as a new paradigm to tackle Parkinson’s disease research challenges
    Virginie Licker, Pierre R. Burkhard · 2014 · Translational Proteomics
78. Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease
    Luke A. Morgan, Oliver Grundmann · 2017 · Journal of Dietary Supplements
79. Emerging roles of protein kinases in microglia-mediated neuroinflammation
    Sun Hwa Lee, Kyoungho Suk · 2017 · Biochemical Pharmacology
80. Ambroxol for the treatment of fibromyalgia: science or fiction?
    Kai‐Uwe Kern, Myriam Schwickert · 2017 · Journal of Pain Research
81. Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation‐mediated neurotoxicity through inhibition of NF‐κB signalling pathway in Parkinson's disease model
    Ping Gan, Qiaofang Xia, Guihua Hang, Yincai Zhou, Xiaojuan Qian, Xiaomei Wang, Lidong Ding · 2018 · Clinical and Experimental Pharmacology and Physiology
82. Immune system and new avenues in Parkinson’s disease research and treatment
    Ava Nasrolahi, Fatemeh Safari, Mehdi Farhoudi, Afra Khosravi, Fereshteh Farajdokht, Saiyad Bastaminejad, Siamak Sandoghchian Shotorbani, Javad Mahmoudi · 2019 · Reviews in the Neurosciences
83. The dynamics of nigrostriatal system damage and neurobehavioral changes in the rotenone rat model of Parkinson’s disease
    Dmitry V. Troshev, D. S. Berezhnoy, Куликова Ольга Игоревна, Д. А. Абаимов, Olga A. Muzychuk, Denis S. Nalobin, Sergey L. Stvolinsky, Т. Н. Федорова · 2021 · Brain Research Bulletin
84. Emerging contributions of formyl peptide receptors to neurodegenerative diseases
    Lukas Busch, Stefan Vieten, Susan Brödel, Kristina Endres, Bernd Bufe · 2021 · Biological Chemistry
85. HIV-1 Myristoylated Nef Treatment of Murine Microglial Cells Activates Inducible Nitric Oxide Synthase, NO2 Production and Neurotoxic Activity
    Giorgio Mangino, Marylinda Famiglietti, Caterina Capone, Caterina Veroni, Zulema Antonia Percario, Stefano Leone, Gianna Fiorucci, Sebastian Lülf, G. Romeo, Cristina Agresti et al. · 2015 · PLoS ONE
86. Imaging multiple sclerosis and other neurodegenerative diseases
    Matilde Inglese, Maria Petracca · 2013 · Prion
87. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats
    Joanna L. Elson, Abi G. Yates, Ilse Sanet Pienaar · 2015 · Brain Structure and Function
88. Innate and adaptive immunity in neurodegenerative disease
    Yeyu Huang, Guoxin Zhang, Sheng Li, Jin Feng, Zhentao Zhang · 2025 · Cellular and Molecular Life Sciences
89. Exploring novel roles of lipid droplets and lipid metabolism in regulating inflammation and blood–brain barrier function in neurological diseases
    Luo Fu, Ting Luo, Zhongnan Hao, Yongli Pan, Wenqiang Xin, Lin Zhang, Zhuhong Lai, Haitao Zhang, Hua Liu, Wei Wei · 2025 · Frontiers in Neuroscience
90. Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
    Yong Hui Koh, Li Yi Tan, Shi‐Yan Ng · 2018 · Frontiers in Cellular Neuroscience
91. PET Neuroimaging in Dementia Conditions
    Daniela Perani, Silvia Paola Caminiti, Giulia Carli, Giacomo Tondo · 2020 · Springer eBooks
92. Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy
    Karen M. Delgado-Minjares, Daniel Martínez‐Fong, Irma Alicia Martínez-Dávila, Cecilia Bañuelos, María Eugenia Gutiérrez-Castillo, Víctor Manuel Blanco-Álvarez, María del Carmen Cárdenas‐Aguayo, José Luna‐Muñoz, Mar Pacheco‐Herrero, Luis Oskar Soto-Rojas · 2021 · International Journal of Molecular Sciences
93. Mechanisms of NLRP3 activation and pathology during neurodegeneration
    Sara Jose, Natalie J. Groves, Kathrein E. Roper, Richard Gordon · 2022 · The International Journal of Biochemistry & Cell Biology
94. Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease
    Yazead Buhidma, Carl Hobbs, Marzia Malcangio, Susan Duty · 2023 · npj Parkinson s Disease
95. Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson’s Disease
    Shane Michael Ravenhill, Andrew H. Evans, Sheila G. Crewther · 2023 · Antioxidants
96. Revealing the mechanisms of blood–brain barrier in chronic neurodegenerative disease: an opportunity for therapeutic intervention
    Sixun Yu, Xin Chen, Tao Yang, Jingmin Cheng, Enyu Liu, Lingli Jiang, Min Song, Haifeng Shu, Yuan Ma · 2024 · Reviews in the Neurosciences
97. The A53T Mutation in α-Synuclein Enhances Proinflammatory Activation in Human Microglia Upon Inflammatory Stimulus
    Marine Krzisch, Bingbing Yuan, Wenyu Chen, Tatsuya Osaki, Dongdong Fu, Carrie M. Garrett-Engele, Devon S. Svoboda, Kristin R. Andrykovich, Michael D. Gallagher, Mriganka Sur et al. · 2024 · Biological Psychiatry
98. Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life
    Lu‐Tai Tien, Asuka Kaizaki, Yi Pang, Zhengwei Cai, Abhay Bhatt, Lir‐Wan Fan · 2013 · Toxicology
99. Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson's Disease
    Roberto Cilia · 2018 · International review of neurobiology
100. High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
     Antonio Heras‐Garvin, Violetta Refolo, Markus Reindl, Gregor Karl Wenning, Nadia Stefanova · 2020 · Journal of Neuroinflammation